July 2017 FDA Recall Pravastatin Sodium by Dr. Reddy's Laboratories, Inc.
D-1038-2017 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Dr. Reddy's Laboratories, Inc. on July 11, 2017 for the product Pravastatin Sodium. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1038-2017

Reason for Recall
Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.
Initiated
07-11-2017
Reported
08-09-2017
Quantity
544 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Dr. Reddy's Laboratories, Inc.
Nationwide in the USA
Pravastatin Sodium Tablets, USP, 10 mg, packaged in a) 90-count bottles (NDC 55111-229-90) and b) 500-count bottles (NDC 55111-229-05), Rx only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA; Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA.

Batch or Lot Expiration Information

Lot# : a) C700220, Exp 06/18; b) C700220, Exp 06/18